Do Rego, Hermann https://orcid.org/0009-0003-5618-6676
Dessajan, Julien
Le Hingrat, Quentin
Lefevre, Laurence Armand
De Montmollin, Etienne
Thy, Michael
Ruckly, Stéphane
Sonneville, Romain
Bouadma, Lila
Grall, Nathalie
Timsit, Jean-François
Article History
Received: 21 April 2025
Accepted: 16 August 2025
First Online: 27 October 2025
Declarations
:
: The trial was approved by the ethics committee of the French Intensive Care Society (CE SRLF 24–086).
: Not applicable.
: JFT declares lectures and scientific adboard participation for Biomerieux, Qiagen, Merck, Pfizer, Shionogi; Menarini, Advanz Pharma out of the submitted work. JD declares honoraria for lectures from BioMérieux.